Search Results - "ZOR EVREN" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study

Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study

by Cervantes, Francisco, Ross, David M., Radinoff, Atanas, Palandri, Francesca, Myasnikov, Alexandr, Vannucchi, Alessandro M., Zachee, Pierre, Gisslinger, Heinz, Komatsu, Norio, Foltz, Lynda, Mannelli, Francesco, Passamonti, Francesco, Gilotti, Geralyn, Sadek, Islam, Tiwari, Ranjan, Zor, Evren, Al-Ali, Haifa Kathrin
Published in Leukemia (01.12.2021)

Get full text

Journal Article

Cardiac and hepatic siderosis in myelodysplastic syndrome, thalassemia and diverse causes of transfusion‐dependent anemia: the TIMES study

Cardiac and hepatic siderosis in myelodysplastic syndrome, thalassemia and diverse causes of transfusion‐dependent anemia: the TIMES study

by Ho, P. Joy, Hiwase, Devendra, Ramakrishna, Raj, Viiala, Nicholas, Solterbeck, Ann, Traficante, Robert, Zor, Evren, Gervasio, Othon L., High, Laura M., Ross, David M., Bowden, Donald K.
Published in HemaSphere (01.06.2019)

Get full text

Journal Article

Uptake of 2-[18F]fluoro-2-deoxy-D-glucose in uterine leiomyoma: imaging of four patients by coincidence positron emission tomography

Uptake of 2-[18F]fluoro-2-deoxy-D-glucose in uterine leiomyoma: imaging of four patients by coincidence positron emission tomography

by Ak, Ilknur, Ozalp, Sinan, Yalçin, Omer T, Zor, Evren, Vardareli, Erkan
Published in Nuclear medicine communications (01.09.2004)

Get more information

Journal Article

RTID-05. TRIAL IN PROGRESS: DOSE-FINDING STUDY AND EVALUATION OF [177LU]LU-DOTA-TATE IN COMBINATION WITH STANDARD OF CARE IN NEWLY DIAGNOSED GLIOBLASTOMA AND AS A SINGLE AGENT IN RECURRENT GLIOBLASTOMA

RTID-05. TRIAL IN PROGRESS: DOSE-FINDING STUDY AND EVALUATION OF [177LU]LU-DOTA-TATE IN COMBINATION WITH STANDARD OF CARE IN NEWLY DIAGNOSED GLIOBLASTOMA AND AS A SINGLE AGENT IN RECURRENT GLIOBLASTOMA

by Wen, Patrick Y, Cloughesy, Timothy, Demange, Arnaud, Herrmann, Ken, Weller, Michael, Zor, Evren
Published in Neuro-oncology (Charlottesville, Va.) (14.11.2022)

Get full text

Journal Article

방사성 핵종 복합체의 조합 요법

방사성 핵종 복합체의 조합 요법

by AIMONE PAOLA DANIELA, ZOR EVREN, MARIANI MAURIZIO F, CHICCO DANIELA
Year of Publication 24.06.2024

Get full text

Patent

Analysis of predictors of response to ruxolitinib in patients with myelofibrosis in the phase 3b expanded-access JUMP study

Analysis of predictors of response to ruxolitinib in patients with myelofibrosis in the phase 3b expanded-access JUMP study

by Gupta, Vikas, Griesshammer, Martin, Martino, Bruno, Foltz, Lynda, Tavares, Renato, Al-Ali, Haifa Kathrin, Giraldo, Pilar, Guglielmelli, Paola, Lomaia, Elza, Bouard, Catherine, Paley, Carole, Tiwari, Ranjan, Zor, Evren, Raanani, Pia
Published in Leukemia & lymphoma (21.03.2021)

Get full text

Journal Article

Long-Term Effect of Ruxolitinib (RUX) in Inadequately Controlled Polycythemia Vera (PV) without Splenomegaly: 5-Year Results from the Phase 3 Response-2 Study

Long-Term Effect of Ruxolitinib (RUX) in Inadequately Controlled Polycythemia Vera (PV) without Splenomegaly: 5-Year Results from the Phase 3 Response-2 Study

by Passamonti, Francesco, Palandri, Francesca, Saydam, Guray, Egyed, Miklos, Callum, Jeannie, Devos, Timothy, Sivgin, Serdar, Guglielmelli, Paola, Vannucchi, Alessandro M., Zor, Evren, Gilotti, Geralyn, Zhang, Yifan, Griesshammer, Martin
Published in Blood (05.11.2020)

Get full text

Journal Article

Ruxolitinib versus best available therapy in inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): 5-year follow up of a randomised, phase 3b study

Ruxolitinib versus best available therapy in inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): 5-year follow up of a randomised, phase 3b study

by Passamonti, Francesco, Palandri, Francesca, Saydam, Guray, Callum, Jeannie, Devos, Timothy, Guglielmelli, Paola, Vannucchi, Alessandro M, Zor, Evren, Zuurman, Mike, Gilotti, Geralyn, Zhang, Yifan, Griesshammer, Martin
Published in The Lancet. Haematology (01.07.2022)

Get more information

Journal Article

Correction: Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study

Correction: Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study

by Cervantes, Francisco, Ross, David M., Radinoff, Atanas, Palandri, Francesca, Myasnikov, Alexandr, Vannucchi, Alessandro M., Zachee, Pierre, Gisslinger, Heinz, Komatsu, Norio, Foltz, Lynda, Mannelli, Francesco, Passamonti, Francesco, Gilotti, Geralyn, Sadek, Islam, Tiwari, Ranjan, Zor, Evren, Al-Ali, Haifa Kathrin
Published in Leukemia (01.12.2021)

Get full text

Journal Article

Baseline Mutational Status of Patients with Myelofibrosis and Anemia in the Realise Trial and Impact on Outcome

Baseline Mutational Status of Patients with Myelofibrosis and Anemia in the Realise Trial and Impact on Outcome

by Al-Ali, Haifa Kathrin, Gisslinger, Heinz, Passamonti, Francesco, Foltz, Lynda, Ross, David M, Vianelli, Nicola, Vannucchi, Alessandro M., Komatsu, Norio, Zachée, Pierre, Tiwari, Ranjan, Zor, Evren, Chaturvedi, Shalini, Gilotti, Geralyn, Cervantes, Francisco
Published in Blood (13.11.2019)

Get full text

Journal Article

Prevalence of Cardiac and Hepatic Siderosis in Australian Patients with Transfusion-Dependent Anemias or Non-Transfusion-Dependent Thalassemia, As Assessed By MRI (the TIMES study)

Prevalence of Cardiac and Hepatic Siderosis in Australian Patients with Transfusion-Dependent Anemias or Non-Transfusion-Dependent Thalassemia, As Assessed By MRI (the TIMES study)

by Ho, Phoebe Joy, Hiwase, Devendra, Ramakrishna, Raj, Viiala, Nicholas, Ross, David M, Zor, Evren, Gervasio, Othon L, Bowden, Donald
Published in Blood (03.12.2015)

Get full text

Journal Article

COMBINATION THERAPY OF RADIONUCLIDE COMPLEX

COMBINATION THERAPY OF RADIONUCLIDE COMPLEX

by AIMONE, Paola Daniela, ZOR, Evren, MARIANI, Maurizio F, CHICCO, Daniela
Year of Publication 04.09.2024

Get full text

Patent

Combination therapy of radionuclide complex

Combination therapy of radionuclide complex

by MARIANI Maurizio F, CHICCO Daniela, AIMONE Paola Daniela, ZOR Evren
Year of Publication 01.06.2024

Get full text

Patent

COMBINATION THERAPY OF RADIONUCLIDE COMPLEX

COMBINATION THERAPY OF RADIONUCLIDE COMPLEX

by AIMONE, Paola Daniela, ZOR, Evren, MARIANI, Maurizio F, CHICCO, Daniela
Year of Publication 11.04.2024

Get full text

Patent

COMBINATION THERAPY OF RADIONUCLIDE COMPLEX

COMBINATION THERAPY OF RADIONUCLIDE COMPLEX

by AIMONE, PAOLA DANIELA, CHICCO, DANIELA, ZOR, EVREN, MARIANI, MAURIZIO F
Year of Publication 04.05.2023

Get full text

Patent

COMBINATION THERAPY OF RADIONUCLIDE COMPLEX

COMBINATION THERAPY OF RADIONUCLIDE COMPLEX

by AIMONE, Paola Daniela, ZOR, Evren, MARIANI, Maurizio F, CHICCO, Daniela
Year of Publication 04.05.2023

Get full text

Patent

COMBINATION THERAPY OF RADIONUCLIDE COMPLEX

COMBINATION THERAPY OF RADIONUCLIDE COMPLEX

by MARIANI Maurizio F, CHICCO Daniela, AIMONE Paola Daniela, ZOR Evren
Year of Publication 08.05.2024

Get full text

Patent

Combination therapy of radionuclide complex

Combination therapy of radionuclide complex

by AIMONE, PAOLA DANIELA, CHICCO, DANIELA, ZOR, EVREN, MARIANI, MAURIZIO F
Year of Publication 16.08.2023

Get full text

Patent